Brett Sandercock
2017
In 2017, Brett Sandercock earned a total compensation of $2.5M as Chief financial officer at ResMed, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $309,411 |
|---|---|
| Option Awards | $437,500 |
| Salary | $442,081 |
| Stock Awards | $1,312,500 |
| Other | $46,502 |
| Total | $2,547,994 |
Sandercock received $1.3M in stock awards, accounting for 52% of the total pay in 2017.
Sandercock also received $309.4K in non-equity incentive plan, $437.5K in option awards, $442.1K in salary and $46.5K in other compensation.
Rankings
In 2017, Brett Sandercock's compensation ranked 4,346th out of 14,666 executives tracked by ExecPay. In other words, Sandercock earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,346 out of 14,666 | 70th |
Division Manufacturing | 1,525 out of 5,772 | 74th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 205 out of 859 | 76th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 111 out of 531 | 79th |
Industry Surgical and Medical Instruments and Apparatus | 68 out of 336 | 80th |
Source: SEC filing on September 25, 2017.
Sandercock's colleagues
We found four more compensation records of executives who worked with Brett Sandercock at ResMed in 2017.